Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Systemic Therapy for Melanoma Brain and Leptomeningeal Metastases.
Sherman WJ, Romiti E, Michaelides L, Moniz-Garcia D, Chaichana KL, Quiñones-Hinojosa A, Porter AB. Sherman WJ, et al. Among authors: porter ab. Curr Treat Options Oncol. 2023 Dec;24(12):1962-1977. doi: 10.1007/s11864-023-01155-3. Epub 2023 Dec 30. Curr Treat Options Oncol. 2023. PMID: 38158477 Review.
The survival outcomes of molecular glioblastoma IDH-wildtype: a multicenter study.
Ramos-Fresnedo A, Pullen MW, Perez-Vega C, Domingo RA, Akinduro OO, Almeida JP, Suarez-Meade P, Marenco-Hillembrand L, Jentoft ME, Bendok BR, Trifiletti DM, Chaichana KL, Porter AB, Quiñones-Hinojosa A, Burns TC, Kizilbash SH, Middlebrooks EH, Sherman WJ. Ramos-Fresnedo A, et al. Among authors: porter ab. J Neurooncol. 2022 Mar;157(1):177-185. doi: 10.1007/s11060-022-03960-6. Epub 2022 Feb 17. J Neurooncol. 2022. PMID: 35175545
The early infiltrative phase of GBM hypothesis: are molecular glioblastomas histological glioblastomas in the making? A preliminary multicenter study.
Ramos-Fresnedo A, Domingo RA, Perez-Vega C, Pullen MW, Akinduro OO, Almeida JP, Jentoft ME, Bendok BR, Chaichana KL, Trifiletti DM, Burns TC, Porter AB, Kizilbash SH, Middlebrooks EH, Quiñones-Hinojosa A, Sherman WJ. Ramos-Fresnedo A, et al. Among authors: porter ab. J Neurooncol. 2022 Jul;158(3):497-506. doi: 10.1007/s11060-022-04040-5. Epub 2022 Jun 14. J Neurooncol. 2022. PMID: 35699848
Predicting access to postoperative treatment after glioblastoma resection: an analysis of neighborhood-level disadvantage using the Area Deprivation Index (ADI).
Rivera Perla KM, Tang OY, Durfey SNM, Vivas-Buitrago T, Sherman WJ, Parney I, Uhm JH, Porter AB, Elinzano H, Toms SA, Quiñones-Hinojosa A. Rivera Perla KM, et al. Among authors: porter ab. J Neurooncol. 2022 Jul;158(3):349-357. doi: 10.1007/s11060-022-04020-9. Epub 2022 May 3. J Neurooncol. 2022. PMID: 35503190
IDH-wild-type glioblastoma cell density and infiltration distribution influence on supramarginal resection and its impact on overall survival: a mathematical model.
Tripathi S, Vivas-Buitrago T, Domingo RA, Biase G, Brown D, Akinduro OO, Ramos-Fresnedo A, Sherman W, Gupta V, Middlebrooks EH, Sabsevitz DS, Porter AB, Uhm JH, Bendok BR, Parney I, Meyer FB, Chaichana KL, Swanson KR, Quiñones-Hinojosa A. Tripathi S, et al. Among authors: porter ab. J Neurosurg. 2021 Oct 29;136(6):1567-1575. doi: 10.3171/2021.6.JNS21925. Print 2022 Jun 1. J Neurosurg. 2021. PMID: 34715662 Free PMC article.
The impact of multiple lesions on progression-free survival of meningiomas: a 10-year multicenter experience.
Ramos-Fresnedo A, Domingo RA, Sanchez-Garavito JE, Perez-Vega C, Akinduro OO, Jentoft ME, Vora SA, Brown PD, Porter AB, Bendok BR, Link MJ, Middlebrooks EH, Trifiletti DM, Chaichana KL, Quiñones-Hinojosa A, Sherman WJ. Ramos-Fresnedo A, et al. Among authors: porter ab. J Neurosurg. 2021 Nov 19;137(1):9-17. doi: 10.3171/2021.8.JNS211252. Print 2022 Jul 1. J Neurosurg. 2021. PMID: 34798603
Clinical evaluation of fitness to drive in patients with brain metastases.
Valencia-Sanchez C, Gorelkin VC, Mrugala MM, Sharma A, Vora SA, Ashman JB, Daniels TB, Halyard MY, Rule WG, Zhang N, Butterfield RJ, Schild SE, Porter AB. Valencia-Sanchez C, et al. Among authors: porter ab. Neurooncol Pract. 2019 Dec;6(6):484-489. doi: 10.1093/nop/npz027. Epub 2019 Jul 3. Neurooncol Pract. 2019. PMID: 31832219 Free PMC article.
Expanding the Spectrum of Radiation Necrosis After Stereotactic Radiosurgery (SRS) for Intracranial Metastases From Lung Cancer: A Retrospective Review.
Sharma A, Mountjoy LJ, Butterfield RJ, Zhang N, Ross HJ, Schild SE, Sio TT, Daniels TB, Paripati HR, Mrugala MM, Vora SA, Patel NP, Zimmerman RS, Ashman JB, Porter AB. Sharma A, et al. Among authors: porter ab. Am J Clin Oncol. 2020 Feb;43(2):128-132. doi: 10.1097/COC.0000000000000642. Am J Clin Oncol. 2020. PMID: 31764021
Clinical Outcomes of Stereotactic Radiosurgery-Related Radiation Necrosis in Patients with Intracranial Metastasis from Melanoma.
Thomson HM, Fortin Ensign SP, Edmonds VS, Sharma A, Butterfield RJ 3rd, Schild SE, Ashman JB, Zimmerman RS, Patel NP, Bryce AH, Vora SA, Sio TT, Porter AB. Thomson HM, et al. Among authors: porter ab. Clin Med Insights Oncol. 2023 Mar 21;17:11795549231161878. doi: 10.1177/11795549231161878. eCollection 2023. Clin Med Insights Oncol. 2023. PMID: 36968334 Free PMC article.
65 results